PTEN and cancer: As a therapeutic strategy for PTEN-related cancer, it may perhaps be possible to target the specific ubiquitin ligase involved in that process, thus blocking pten degradation and maintaining, or restoring, some phosphatase activity that could prevent akt pathway activation.